For in vitro laboratory research only. Not for human or veterinary consumption.
India Warehouse TACROLIMUS 0.03% topical — 20gm. Topical calcineurin inhibitor for atopic dermatitis (eczema) and other inflammatory skin conditions. Non-steroidal alternative — no skin thinning risk. Key warning: Black box warning: theoretical malignancy risk (lymphoma) with prolonged use — use minimum effective duration. Not for children under 2. Avoid sun exposure. Do not use on infected skin.
Topical calcineurin inhibitor for atopic dermatitis (eczema) and other inflammatory skin conditions. Non-steroidal alternative — no skin thinning risk.
How it Works
Inhibits calcineurin → blocks T-cell activation and inflammatory cytokine production (IL-2, IL-4, IL-5, IFN-γ) → reduces skin inflammation without steroid side effects.
Quick Specs
Form
Topical ointment
Active Ingredient
TACROLIMUS
Concentration
0.03%
Size
20gm
Storage
Room temperature (15–25°C), cool dry place away from light
Shelf Life
2–3 years (properly stored)
Common Side Effects
Burning/stinging on application (usually subsides after first week), skin infections.
Safety Warnings
Black box warning: theoretical malignancy risk (lymphoma) with prolonged use — use minimum effective duration. Not for children under 2. Avoid sun exposure. Do not use on infected skin.
International shipping: 7–14 days
Research use only
This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.
